Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Cho

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
International Journal of Molecular Sciences|March 13, 2025
Development of a PLA Polymer-Based Liquid Filler for Next-Generation AestheticsJi Hyun Sung, Na Jeong Park, Jeong Eun Park, et al.
ACS Omega|June 15, 2026
Development of a Rapid-Acting Oxidized Regenerated Cellulose-Based Powder for Hemostatic ApplicationsHyung Hwan Kim, Joo Hang Lee, Jeong Eun Park, et al.
Genes & Development|January 20, 2004
A methylation-mediator complex in hormone signalingWei Xu, Helen Cho, Shilpa Kadam, et al.
Cancer Immunology, Immunotherapy : CII|July 13, 2022
Preclinical development of a vaccine-based immunotherapy regimen (VBIR) that induces potent and durable T cell responses to tumor-associated self-antigensHelen Cho, Joe Binder, Risini Weeratna, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 30, 2008
Pharmacological characterization of a small molecule inhibitor of c-Jun kinaseHelen Cho, Shawn C Black, David Looper, et al.
Journal for Immunotherapy of Cancer|March 22, 2023
First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC)Karen A Autio, Celestia S Higano, Luke Nordquist, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
International Journal of Molecular Sciences|March 13, 2025
Development of a PLA Polymer-Based Liquid Filler for Next-Generation AestheticsJi Hyun Sung, Na Jeong Park, Jeong Eun Park, et al.
ACS Omega|June 15, 2026
Development of a Rapid-Acting Oxidized Regenerated Cellulose-Based Powder for Hemostatic ApplicationsHyung Hwan Kim, Joo Hang Lee, Jeong Eun Park, et al.
Genes & Development|January 20, 2004
A methylation-mediator complex in hormone signalingWei Xu, Helen Cho, Shilpa Kadam, et al.
Cancer Immunology, Immunotherapy : CII|July 13, 2022
Preclinical development of a vaccine-based immunotherapy regimen (VBIR) that induces potent and durable T cell responses to tumor-associated self-antigensHelen Cho, Joe Binder, Risini Weeratna, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 30, 2008
Pharmacological characterization of a small molecule inhibitor of c-Jun kinaseHelen Cho, Shawn C Black, David Looper, et al.
Journal for Immunotherapy of Cancer|March 22, 2023
First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC)Karen A Autio, Celestia S Higano, Luke Nordquist, et al.
Pageof 2